Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06687213

Effect of Smoking Cessation on Glycemic Control in Type 2 Diabetics

Effect of Smoking Cessation on Glycemic Control in Patients with Type 2 Diabetes

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
178 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
35 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The goal of this observational study is to learn about the long-term effects of smoking cessation on glycemic control in type 2 diabetic patients The main question it aims to answer is: Does smoking cessation lower HbA1c in type 2 diabetics on long term ? The participants will be counseled to cessate smoking and will be followed for 6 months and compared to control who will not cessate smoking .

Detailed description

Smoking and diabetes are both major public health issues specially in our community. They act synergistically on morbidity and mortality. Diabetic smokers have much higher rates of micro and macrovascular complications. \[Carole Clair et al., 2020\] Approximately 1.3 billion people worldwide use tobacco, most commonly in the form of tobacco smoking, and more than 7 million people die every year as a result of smoking related conditions \[Magdalena Walicka et al.,2022\] Exposure to cigarette smoke is associated with vascular damage, endothelial dysfunction, and activation of oxidative stress, inflammatory pathways, coagulation, and fibrinolysis A similar mechanism of endothelial dysfunction is described for people with diabetes. It is therefore not surprising that smoking enhances the combined harmful effects of elevated blood glucose levels, accelerating vascular damage in diabetic patients who smoke The prevalence of current smoking was 45.5% in male patients with type 2 diabetes. The levels of fasting blood glucose and HbA1c increased with number of cigarettes smoked per day compared with non-smokers Smoking and its cessation showed dose- and time-dependent relationship with glycemic control and insulin resistance in patients with type 2 diabetes mellitus. These findings may highlight the importance of smoking cessation in the clinical management of diabetes mellitus. the effect of smoking and its cessation on glycemic control in diabetic patients has not been fully examined yet. There is lack of evidence regarding interventions for smoking cessation among individuals with diabetes

Conditions

Interventions

TypeNameDescription
BEHAVIORALSmoking cessation counselling groupCase group will be counseled to cessate smoking and will be followed up with HbA1c

Timeline

Start date
2024-11-01
Primary completion
2025-11-01
Completion
2025-12-01
First posted
2024-11-13
Last updated
2024-11-13

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06687213. Inclusion in this directory is not an endorsement.